- Takeda (TAK, Financial) opens applications for the 2026 Innovators in Science Award, focusing on gastrointestinal and inflammatory diseases, neuroscience, and oncology.
- Three category winners will each receive $75,000, and a grand prize winner will receive an additional $175,000, totaling $250,000.
- The award offers a 12-month career development program in partnership with Nature, including mentorship and skill-building opportunities.
Takeda Pharmaceutical Company Limited (TAK) has announced that submissions are now open for the 2026 Innovators in Science Award. The award aims to recognize emerging biomedical researchers who are making significant contributions in the fields of gastrointestinal and inflammatory diseases, neuroscience, and oncology. Since its inception in 2016, the award has been a cornerstone of Takeda’s effort to promote scientific excellence and encourage innovation among early-career scientists.
This prestigious award will honor three category winners, each of whom will receive a $75,000 prize. In addition, a grand prize winner will be awarded an extra $175,000, culminating in a total grand prize of $250,000. The grand prize will be announced at a live gala event on April 9, 2026, in Boston. The initiative is aimed at celebrating the groundbreaking research and the promising future of young scientists globally.
Those who are named category winners and shortlisted applicants will benefit from a one-year career development program administered by Nature. This program is designed to enhance skills in areas such as grant writing, research communication, and laboratory management and will also provide mentorship opportunities to support the scientists' professional growth.
Applications for the Innovators in Science Award can be submitted through their official website until September 16, 2025. Shortlisted applicants will be revealed in January 2026, followed by the announcement of category winners in February 2026, prior to the gala event.
This global award is part of Takeda’s enduring commitment to fostering a culture of partnership between industry and academia. By offering substantial funding, networking, and development opportunities, Takeda continues to encourage and support emerging scientific leaders who are poised to make transformative impacts across the healthcare landscape.
